Addex Therapeutics

ADXN-CH:SWX

Biotechnology

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2020

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Biotechnology Founded 2002

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

website

Headquarters

Plan-les-Ouates

12, Chemin des Aulx

Geneva, Geneve (Geneva) 1228

41.22.884.15.55

Executives

Name	Title	Gender
Vincent Mutel, PhD	Founder	Male
Timothy Dyer	Chief Executive Officer	Male
Mark s Epping-Jordan, PhD	Founder	Male
Vincent M. Lawton, PhD	Chairman	Male
Roger G. Mills, MD	Chief Medical Officer	Male
Sonia Maria Poli, PhD	Chief Scientific Officer	Female

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Addex Therapeutics - Competitors and Related Companies

How Addex Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.